Patient-reported outcomes in elderly bevazizumab-treated primary ovarian cancer patients: OTILIA study on behalf of the north-eastern german society of gynaecological oncology.

Sehouli, J., Wimberger, P., Oskay-Oezcelik, G., Jungberg, P., Meinerz, W., Janssen, J., Keller, M., Richter, R., Harde, J., Klawitter, S., Wegenaer, A., Mueller, M., Mustea, A., 2016.

IGCS-0471

Studie: OTILIA; Indikation: Sonstige; Jahr: 2016; Veranstaltung: IGCS; Journal: -

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com